Tapan M. Kadia, Hagop Kantarjian, Steven Kornblau, Gautam Borthakur, Stefan Faderl, Emil J. Freireich, Raja Luthra, Guillermo Garcia-Manero, Sherry Pierce, Jorge Cortes and Farhad Ravandi Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS Cancer 118
Version of Record online: 8 MAY 2012 | DOI: 10.1002/cncr.27596
Activating mutations in RAS are frequently present in acute myeloid leukemia and are associated with certain cytogenetic and morphologic subtypes. In the current study, RAS mutations did not appear to have a prognostic impact on outcome overall or within subgroups.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field